Literature DB >> 27582382

Recognizing the tenascin-X deficient type of Ehlers-Danlos syndrome: a cross-sectional study in 17 patients.

S Demirdas1,2, E Dulfer3, L Robert4, M Kempers2, D van Beek5, D Micha5, B G van Engelen6, B Hamel2, J Schalkwijk6, B Loeys2,7, A Maugeri5, N C Voermans8.   

Abstract

The tenascin-X (TNX) deficient type Ehlers-Danlos syndrome (EDS) is similar to the classical type of EDS. Because of the limited awareness among geneticists and the challenge of the molecular analysis of the TNXB gene, the TNX-deficient type EDS is probably to be under diagnosed. We therefore performed an observational, cross-sectional study. History and physical examination were performed. Results of serum TNX measurements were collected and mutation analysis was performed by a combination of next-generation sequencing (NGS), Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA). Included were 17 patients of 11 families with autosomal recessive inheritance and childhood onset. All patients had hyperextensible skin without atrophic scarring. Hypermobility of the joints was observed in 16 of 17 patients. Deformities of the hands and feet were observed frequently. TNX serum level was tested and absent in 11 patients (seven families). Genetic testing was performed in all families; 12 different mutations were detected, most of which are suspected to lead to non-sense mRNA mediated decay. In short, patients with the TNX-deficient type EDS typically have generalized joint hypermobility, skin hyperextensibility and easy bruising. In contrast to the classical type, the inheritance pattern is autosomal recessive and atrophic scarring is absent. Molecular analysis of TNXB in a diagnostic setting is challenging.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  EDS; Ehlers-Danlos syndrome; TNX; TNXB gene; tenascin-X

Mesh:

Substances:

Year:  2016        PMID: 27582382     DOI: 10.1111/cge.12853

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  18 in total

Review 1.  Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome.

Authors:  Walter L Miller; Deborah P Merke
Journal:  Horm Res Paediatr       Date:  2018-05-07       Impact factor: 2.852

2.  High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia.

Authors:  Qizong Lao; Brittany Brookner; Deborah P Merke
Journal:  J Mol Diagn       Date:  2019-06-21       Impact factor: 5.568

3.  Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.

Authors:  Lucia Micale; Carmela Fusco; Marco Castori
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.

Authors:  Pavlos Fanis; Nicos Skordis; Leonidas A Phylactou; Vassos Neocleous
Journal:  Hormones (Athens)       Date:  2022-10-20       Impact factor: 3.419

5.  The extracellular matrix glycoprotein tenascin-X regulates peripheral sensory and motor neurones.

Authors:  Rubina Aktar; Madusha Peiris; Asma Fikree; Vincent Cibert-Goton; Maxim Walmsley; Iain R Tough; Paulo Watanabe; Eduardo J A Araujo; Sahar D Mohammed; Jean-Marie Delalande; David C Bulmer; S Mark Scott; Helen M Cox; Nicol C Voermans; Qasim Aziz; L Ashley Blackshaw
Journal:  J Physiol       Date:  2018-07-18       Impact factor: 5.182

6.  Mechanical allodynia in mice with tenascin-X deficiency associated with Ehlers-Danlos syndrome.

Authors:  Emiko Okuda-Ashitaka; Yuka Kakuchi; Hiroaki Kakumoto; Shota Yamanishi; Hiroki Kamada; Takafumi Yoshidu; Satoshi Matsukawa; Naoya Ogura; Sadahito Uto; Toshiaki Minami; Seiji Ito; Ken-Ichi Matsumoto
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

7.  Transcriptome profiling identifies regulators of pathogenesis in collagen VI related muscular dystrophy.

Authors:  Russell J Butterfield; Diane M Dunn; Ying Hu; Kory Johnson; Carsten G Bönnemann; Robert B Weiss
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

Review 8.  Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review.

Authors:  Sanne D'hondt; Tim Van Damme; Fransiska Malfait
Journal:  Genet Med       Date:  2017-10-05       Impact factor: 8.822

9.  Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.

Authors:  Marco Ritelli; Marina Venturini; Valeria Cinquina; Nicola Chiarelli; Marina Colombi
Journal:  Orphanet J Rare Dis       Date:  2020-07-31       Impact factor: 4.123

10.  A novel role for the extracellular matrix glycoprotein-Tenascin-X in gastric function.

Authors:  Rubina Aktar; Madusha Peiris; Asma Fikree; Simon Eaton; Stamatiki Kritas; Stephen J Kentish; Eduardo J A Araujo; Cristiano Bacarin; Amanda J Page; Nicol C Voermans; Qasim Aziz; L Ashley Blackshaw
Journal:  J Physiol       Date:  2019-01-23       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.